Selektive Östrogenrezeptormodulatoren (SERMs)-Reference-Cited by-同舟云学术

Selektive Östrogenrezeptormodulatoren (SERMs)

Published:2008-10-31 Issue:4 Volume:6 Page:205-212
ISSN:1610-2894
Container-title:Gynäkologische Endokrinologie
language:de
Short-container-title:Gynäkologische Endokrinologie

Author:

Schaudig K.,Schwenkhagen A.

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology,Reproductive Medicine,Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology and Child Health

Link

http://link.springer.com/content/pdf/10.1007/s10304-008-0266-5.pdf

Reference38 articles.

1. Abrams JS (2001) Tamoxifen: five years versus ten years – is the end in sight? J Natl Cancer Inst 93: 662–664

2. Barrett-Connor E, Mosca L, Collins P et al. (2006) Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Eng J Med 355: 125–137

3. Beck JI, Boothroyd C, Proctor M et al. (2005) Oral anti-oestrogens and medical adjuncts for subfertility associated with anovulation. Cochrane Database Syst Rev 2005 1: CD002249

4. Carpenter KD, Korach KS (2006). Potential biological functions emerging from the different estrogen receptors. Ann N Y Acad Sci 1092: 361–373

5. Chang J, Powles TJ, Ashley SE et al. (1996) The effect of tamoxifen and hormone replacement therapy on serum cholesterol, bone mineral density and coagulation factors in healthy postmenopausal women participating in a randomised, controlled tamoxifen prevention study. Ann Oncol 7: 671–675

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2-Phenyl-1-[4-(2-piperidine-1-yl-ethoxy)benzyl]-1H-benzimidazoles as ligands for the estrogen receptor: Synthesis and pharmacological evaluation;Bioorganic & Medicinal Chemistry;2010-07